Pectoserratus Block + Interscalene Block for Shoulder Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether adding a pectoserratus block (a type of nerve block) to the standard interscalene block can better manage pain and reduce opioid use after shoulder replacement surgery. This procedure might cover more areas affected during surgery, potentially lowering pain and opioid use. It suits adults undergoing total or reverse shoulder replacement surgery, excluding those with severe lung issues or existing nerve damage. Participants will be randomly assigned to receive either bupivacaine (a numbing medication) or saline as part of the pectoserratus block. As a Phase 4 trial, this study involves an FDA-approved treatment and aims to understand its benefits for more patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it does exclude patients who are currently using opioids or have chronic pain.
What is the safety track record for the Interscalene Block and Pectoserratus Block treatments?
Research has shown that both the interscalene block (ISB) and the pectoserratus block are generally safe for individuals undergoing shoulder surgery. Studies have found that ISB effectively manages shoulder pain and is well-tolerated, even in patients with other health conditions.
The pectoserratus block is often used to relieve pain after chest or rib surgeries. Patients have reported pain relief with few side effects, indicating its safety for shoulder surgery as well.
Overall, both treatments maintain a strong safety record, with no major issues reported in the studies.12345Why are researchers enthusiastic about this study treatment?
The Pectoserratus Block combined with the Interscalene Block is unique because it offers a potentially enhanced method of pain management for shoulder surgery, which is commonly addressed with general anesthesia and opioid medications. Unlike traditional options that often rely heavily on opioids, this technique uses a local anesthetic approach, which can reduce the risk of opioid-related side effects and improve recovery times. Researchers are particularly excited about the possibility of providing effective pain relief with less reliance on narcotics, potentially leading to better patient outcomes and a smoother post-surgery experience.
What evidence suggests that the addition of a pectoserratus block to an interscalene block could be effective for improving pain control and reducing opioid use in shoulder surgery?
Research has shown that the interscalene block (ISB) effectively relieves pain in shoulder surgeries and is considered the best method for reducing pain and limiting opioid use. However, it does not relieve pain in all areas affected by total shoulder replacement surgery. In this trial, some participants will receive the pectoserratus block in addition to the ISB. The pectoserratus block can help by covering more areas affected by the surgery. Studies have demonstrated that adding the pectoserratus block can further reduce pain and decrease the need for opioids. This combination aims to provide better pain management for patients undergoing total shoulder replacement.12456
Who Is on the Research Team?
Jacob Hutchins, MD, MHA
Principal Investigator
University of Minnesota
Are You a Good Fit for This Trial?
This trial is for patients aged 18-85 undergoing total shoulder replacement surgery. It's suitable for those who can receive an ultrasound-guided block as part of their pain management.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a pectoserratus block with bupivacaine or saline during total shoulder arthroplasty
Postoperative Monitoring
Participants are monitored for pain and opioid use within the first 48 hours post-operation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including hospital length of stay and functional pain score
What Are the Treatments Tested in This Trial?
Interventions
- Interscalene Block
- Pectoserratus Block
Interscalene Block is already approved in United States, European Union, Canada for the following indications:
- Shoulder surgery
- Total shoulder arthroplasty
- Reverse total shoulder arthroplasty
- Shoulder surgery
- Total shoulder arthroplasty
- Reverse total shoulder arthroplasty
- Shoulder surgery
- Total shoulder arthroplasty
- Reverse total shoulder arthroplasty
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor